Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Revolutionary Advances for Treating Urothelial Carcinoma
EP. 1: Revolutionary Advances for Treating Urothelial Carcinoma
April 22nd 2017
EP. 2: Bladder Cancer: Paradigm Changing Advances in Treatment
April 22nd 2017
EP. 3: Durvalumab FDA Approval for Bladder Cancer
April 22nd 2017
EP. 4: Historic Perspective on Bladder Cancer Treatment
April 22nd 2017
EP. 5: Frontline Atezolizumab for Advanced Bladder Cancer
April 22nd 2017
EP. 6: FDA Approval of Durvalumab for Bladder Cancer
April 22nd 2017
EP. 7: Treatment of Bladder Cancer-Immune Checkpoint Inhibitors
April 22nd 2017
EP. 8: FDA Approval of Durvalumab for Advanced Bladder Cancer
April 22nd 2017
EP. 9: Promising Treatment Options for Advanced Bladder Cancer
April 22nd 2017
EP. 10: Immune Checkpoint Inhibitors for Advanced Bladder Cancer
April 22nd 2017
EP. 11: Durvalumab for Treatment of Advanced Bladder Cancer
April 22nd 2017
EP. 12: Future Treatment Options for Advanced Bladder Cancer
April 22nd 2017
EP. 13: Use of Immune Checkpoint Inhibitors for Bladder Cancer
April 22nd 2017
EP. 14: Highlights of Durvalumab for Advanced Bladder Cancer
April 22nd 2017
EP. 15: Combination Therapies for Advanced Bladder Cancer
April 22nd 2017
x